Published in PLoS One on December 01, 2016
International Union of Basic and Clinical Pharmacology. LXXIII. Nomenclature for the formyl peptide receptor (FPR) family. Pharmacol Rev (2009) 3.65
Respiratory burst in human neutrophils. J Immunol Methods (1999) 3.16
Human formyl peptide receptor 2 senses highly pathogenic Staphylococcus aureus. Cell Host Microbe (2010) 2.64
Activation of lipoxin A(4) receptors by aspirin-triggered lipoxins and select peptides evokes ligand-specific responses in inflammation. J Exp Med (2000) 2.01
H2-M3-restricted T cells in bacterial infection: rapid primary but diminished memory responses. J Exp Med (1999) 1.70
Separation of leucocytes: improved cell purity by fine adjustments of gradient medium density and osmolality. Scand J Immunol (1991) 1.64
Ligand recognition and activation of formyl peptide receptors in neutrophils. J Leukoc Biol (2005) 1.49
A Listeria monocytogenes pentapeptide is presented to cytolytic T lymphocytes by the H2-M3 MHC class Ib molecule. Immunity (1996) 1.41
Nonclassical binding of formylated peptide in crystal structure of the MHC class Ib molecule H2-M3. Cell (1995) 1.37
Changes in activation states of murine polymorphonuclear leukocytes (PMN) during inflammation: a comparison of bone marrow and peritoneal exudate PMN. Clin Vaccine Immunol (2006) 1.34
Mitochondria in innate immunity. EMBO Rep (2011) 1.31
A critical role for the g protein-coupled receptor mFPR2 in airway inflammation and immune responses. J Immunol (2010) 1.26
Measurement of respiratory burst products, released or retained, during activation of professional phagocytes. Methods Mol Biol (2014) 1.17
Cyclosporin H, Boc-MLF and Boc-FLFLF are antagonists that preferentially inhibit activity triggered through the formyl peptide receptor. Inflammation (2007) 1.17
Induction of M3-restricted cytotoxic T lymphocyte responses by N-formylated peptides derived from Mycobacterium tuberculosis. J Exp Med (2001) 1.05
Basic characteristics of the neutrophil receptors that recognize formylated peptides, a danger-associated molecular pattern generated by bacteria and mitochondria. Biochem Pharmacol (2016) 1.02
H2-M3-restricted T cell response to infection. Microbes Infect (2006) 1.00
Receptor-dependent and -independent immunomodulatory effects of phenol-soluble modulin peptides from Staphylococcus aureus on human neutrophils are abrogated through peptide inactivation by reactive oxygen species. Infect Immun (2012) 0.96
Functional characterization of three mouse formyl peptide receptors. Mol Pharmacol (2012) 0.95
Biochemical specificity of H-2M3a. Stereospecificity and space-filling requirements at position 1 maintain N-formyl peptide binding. J Immunol (1992) 0.93
Reactive oxygen production induced by the gut microbiota: pharmacotherapeutic implications. Curr Med Chem (2012) 0.91
The annexin I sequence gln(9)-ala(10)-trp(11)-phe(12) is a core structure for interaction with the formyl peptide receptor 1. J Biol Chem (2010) 0.91
Development of small molecule non-peptide formyl peptide receptor (FPR) ligands and molecular modeling of their recognition. Curr Med Chem (2014) 0.89
Structural characterization and inhibitory profile of formyl peptide receptor 2 selective peptides descending from a PIP2-binding domain of gelsolin. J Immunol (2012) 0.88
Discovery of selective probes and antagonists for G-protein-coupled receptors FPR/FPRL1 and GPR30. Curr Top Med Chem (2009) 0.85
The FPR2-specific ligand MMK-1 activates the neutrophil NADPH-oxidase, but triggers no unique pathway for opening of plasma membrane calcium channels. Cell Calcium (2009) 0.85
N-Formyl peptides drive mitochondrial damage associated molecular pattern induced neutrophil activation through ERK1/2 and P38 MAP kinase signalling pathways. Injury (2015) 0.82
Structural determinants for the interaction of formyl peptide receptor 2 with peptide ligands. J Biol Chem (2013) 0.81
Changes in the ratio between FPR and FPRL1 triggered superoxide production in human neutrophils-a tool in analysing receptor specific events. J Immunol Methods (2007) 0.80
Structural changes of the ligand and of the receptor alters the receptor preference for neutrophil activating peptides starting with a formylmethionyl group. Biochim Biophys Acta (2014) 0.80
The peptidomimetic Lau-(Lys-βNSpe)6-NH2 antagonizes formyl peptide receptor 2 expressed in mouse neutrophils. Biochem Pharmacol (2016) 0.80
Role of MHC class Ib molecule, H2-M3 in host immunity against tuberculosis. Vaccine (2013) 0.79
The Lipidated Peptidomimetic Lau-((S)-Aoc)-(Lys-βNphe)6-NH2 Is a Novel Formyl Peptide Receptor 2 Agonist That Activates Both Human and Mouse Neutrophil NADPH Oxidase. J Biol Chem (2016) 0.77
The Neutrophil Response Induced by an Agonist for Free Fatty Acid Receptor 2 (GPR43) Is Primed by Tumor Necrosis Factor Alpha and by Receptor Uncoupling from the Cytoskeleton but Attenuated by Tissue Recruitment. Mol Cell Biol (2016) 0.75
Formyl peptide derived lipopeptides disclose differences between the receptors in mouse and men and call the pepducin concept in question. PLoS One (2017) 0.75